Back
Cidara Therapeutics Stock Predictions
Sell
34
CDTX
Cidara Therapeutics
Last Price:
11.21
Seasonality Move:
-3.38%
7 Day Trial
ALL ACCESS PASS
$
7
Cidara Therapeutics Stock Forecast
- Over the next 52 weeks, Cidara Therapeutics has on average historically fallen by 10.2% based on the past 9 years of stock performance.
- Cidara Therapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
-
Is Cidara Therapeutics Stock Undervalued?
The current Cidara Therapeutics [CDTX] share price is $11.21. The Score for CDTX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal. - CDTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Cidara Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Cidara Therapeutics has on average historically fallen by 10.2% based on the past 9 years of stock performance.
Cidara Therapeutics Stock Rating
Sell
34
Cidara Therapeutics (CDTX)
is a Sell
Is Cidara Therapeutics overpriced?
- Cidara Therapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
Cidara Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cidara.com
52-Week Data
52-Week High:
29.60
52-Week Low:
10.00
Prediction Charts
Market Cap:
51.14M
Price in USD:
11.21
Volume:
60.75K
Beta:
1.38
Technical Analysis
SMA50:
14.76
SMA100:
14.57
SMA200:
15.86
52-Wk Change:
-58.48%
Stock Predictions
-
Is Cidara Therapeutics stock public?
Yes, Cidara Therapeutics is a publicly traded company. -
What is the Cidara Therapeutics stock quote today?
The Cidara Therapeutics stock price is 11.21 USD today. -
How to buy Cidara Therapeutics stock online?
You can buy Cidara Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 12.20 | 11.98 | 12.64 | 11.72 |
May-1 | 11.85 | 11.81 | 11.86 | 11.02 |
May-2 | 11.84 | 12.57 | 12.85 | 11.52 |
May-3 | 11.75 | 12.51 | 13.20 | 11.75 |
May-6 | 12.60 | 13.68 | 14.09 | 12.60 |
May-7 | 13.73 | 13.46 | 14.12 | 13.41 |
May-8 | 13.39 | 13.05 | 13.59 | 13.04 |
May-9 | 13.32 | 12.60 | 13.57 | 12.60 |
May-10 | 12.60 | 12.16 | 13.04 | 12.16 |
May-13 | 12.25 | 12.70 | 12.70 | 12.25 |
May-14 | 12.60 | 13.09 | 13.44 | 12.33 |
May-15 | 13.13 | 12.71 | 13.13 | 12.54 |
May-16 | 12.28 | 12.00 | 12.70 | 11.85 |
May-17 | 12.00 | 11.21 | 12.00 | 10.88 |
Cidara Therapeutics Earnings
Cidara Therapeutics Earnings Report: Per Share Cidara Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cidara Therapeutics Forecast Revenue Growth
Cidara Therapeutics Stock Analysis: Historical quarterly revenues per share for Cidara Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.58 per share, and an increase next year of $14.81 per share.
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.